Heartflow, Inc. (NASDAQ:HTFL - Get Free Report) CEO John C.M. Farquhar sold 15,560 shares of the stock in a transaction that occurred on Friday, August 14th. The stock was sold at an average price of $39.06, for a total transaction of $607,773.60. Following the sale, the chief executive officer directly owned 420,720 shares of the company's stock, valued at approximately $16,433,323.20. This trade represents a 3.57% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
John C.M. Farquhar also recently made the following trade(s):
- On Monday, August 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $28.31, for a total transaction of $638,730.22.
- On Friday, July 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $27.75, for a total transaction of $626,095.50.
- On Wednesday, June 24th, John C.M. Farquhar sold 38,900 shares of Heartflow stock. The stock was sold at an average price of $35.00, for a total transaction of $1,361,500.00.
- On Wednesday, June 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $28.50, for a total transaction of $643,017.00.
Heartflow Trading Up 7.8%
Shares of Heartflow stock opened at $45.23 on Wednesday. The company has a fifty day moving average price of $29.68 and a 200 day moving average price of $27.95. Heartflow, Inc. has a twelve month low of $20.13 and a twelve month high of $45.33. The stock has a market cap of $3.90 billion and a price-to-earnings ratio of -24.72.
Heartflow (NASDAQ:HTFL - Get Free Report) last released its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.22) by $0.15. The company had revenue of $64.08 million for the quarter. Heartflow had a negative return on equity of 23.50% and a negative net margin of 55.82%.Heartflow's revenue was up 47.7% compared to the same quarter last year. Analysts forecast that Heartflow, Inc. will post -0.82 earnings per share for the current year.
Hedge Funds Weigh In On Heartflow
Institutional investors and hedge funds have recently made changes to their positions in the business. Caitong International Asset Management Co. Ltd acquired a new stake in Heartflow in the fourth quarter valued at $27,000. Russell Investments Group Ltd. acquired a new position in Heartflow during the 4th quarter worth $45,000. Essential Partners LLC bought a new stake in shares of Heartflow in the 1st quarter worth about $57,000. Legal & General Group Plc acquired a new stake in shares of Heartflow in the 3rd quarter valued at about $59,000. Finally, Strs Ohio acquired a new stake in shares of Heartflow in the 4th quarter valued at about $99,000.
Wall Street Analysts Forecast Growth
Several analysts have issued reports on the stock. Morgan Stanley increased their price objective on shares of Heartflow from $35.00 to $40.00 and gave the company an "equal weight" rating in a research report on Friday. Benchmark reissued a "buy" rating on shares of Heartflow in a research report on Friday. Robert W. Baird set a $45.00 price target on shares of Heartflow in a report on Friday. Wells Fargo & Company lifted their price target on shares of Heartflow from $37.00 to $39.00 and gave the stock an "overweight" rating in a research note on Friday, August 14th. Finally, JPMorgan Chase & Co. upped their price objective on shares of Heartflow from $35.00 to $45.00 and gave the company an "overweight" rating in a research report on Friday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $43.43.
Check Out Our Latest Stock Report on HTFL
About Heartflow
(
Get Free Report)
HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company's core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow's analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.
HeartFlow's cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
